Gemcitabine, Cisplatin Clinical Trials
3 recruitingDrug
Phase 12Phase 22
Showing 1–3 of 3 trials
Recruiting
Phase 2
Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
Biliary Tract CancerCholangiocarcinomaGall Bladder Cancer+1 more
First Affiliated Hospital of Zhejiang University60 enrolled1 locationNCT07025174
Recruiting
Phase 1Phase 2
EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
Nasopharyngeal Cancinoma (NPC)Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharynx Carcinoma
Sun Yat-Sen University Cancer Center148 enrolled1 locationNCT06802835
Recruiting
Phase 1
Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer
Muscle Invasive Bladder Cancer
First Affiliated Hospital of Chongqing Medical University10 enrolled1 locationNCT06916494